Novolog 100 unit/ML flexpen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV867
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,228
Award facts
- Contract value 100% obligated
- $10,228.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,228.41 to Amerisourcebergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract, which became effective on January 28, 2026, with an ultimate completion date of January 29, 2026, is structured as a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's parent organization, Cencora, Inc., which holds a comprehensive Indefinite Delivery Contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031.
The underlying indefinite delivery vehicle enables DLA to procure a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and other critical medical commodities. Cencora, Inc., operating as Amerisourcebergen, competes on a full and open basis for federal contracts and serves as a critical vendor for military and veteran healthcare systems. This specific delivery order for insulin pens reflects the ongoing pharmaceutical supply needs of the Defense Health Agency and other federal medical institutions supported through the DLA's comprehensive pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DR26FV867?
SPE2DR26FV867 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FV867 worth?
The government has obligated $10,228 on SPE2DR26FV867.
Is contract SPE2DR26FV867 an order under another contract?
Yes. SPE2DR26FV867 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV867 competed?
The extent of competition for SPE2DR26FV867 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award